188 related articles for article (PubMed ID: 14583867)
1. Pneumonia in older persons.
Loeb M
Clin Infect Dis; 2003 Nov; 37(10):1335-9. PubMed ID: 14583867
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of pneumococcal polysaccharide vaccine in older adults.
Jackson LA; Neuzil KM; Yu O; Benson P; Barlow WE; Adams AL; Hanson CA; Mahoney LD; Shay DK; Thompson WW;
N Engl J Med; 2003 May; 348(18):1747-55. PubMed ID: 12724480
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal vaccination in the prevention of community-acquired pneumonia: an optimistic view of cost-effectiveness.
Fedson DS
Semin Respir Infect; 1993 Dec; 8(4):285-93. PubMed ID: 7938925
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of community- and nursing home-acquired pneumonia in older adults.
Loeb M
Expert Rev Anti Infect Ther; 2005 Apr; 3(2):263-70. PubMed ID: 15918783
[TBL] [Abstract][Full Text] [Related]
5. [Prevention of community-acquired pneumonia in adults].
Barros M M; Cartagena S C; Bavestrello F L
Rev Chilena Infectol; 2005; 22 Suppl 1():s67-74. PubMed ID: 16163421
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccination.
Williams RM
Lippincotts Prim Care Pract; 1998; 2(6):625-33. PubMed ID: 9883157
[TBL] [Abstract][Full Text] [Related]
7. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
Ioachimescu OC; Ioachimescu AG; Iannini PB
Int J Antimicrob Agents; 2004 Nov; 24(5):485-90. PubMed ID: 15519482
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults.
Hak E; Grobbee DE; Sanders EA; Verheij TJ; Bolkenbaas M; Huijts SM; Gruber WC; Tansey S; McDonough A; Thoma B; Patterson S; van Alphen AJ; Bonten MJ
Neth J Med; 2008 Oct; 66(9):378-83. PubMed ID: 18990781
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal vaccine in the prevention of community-acquired pneumonia: a skeptical view of cost-effectiveness.
Simberkoff MS
Semin Respir Infect; 1993 Dec; 8(4):294-9. PubMed ID: 7938926
[TBL] [Abstract][Full Text] [Related]
10. Community-acquired pneumonia in the elderly.
Marrie TJ
Clin Infect Dis; 2000 Oct; 31(4):1066-78. PubMed ID: 11049791
[TBL] [Abstract][Full Text] [Related]
11. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.
Johnstone J; Eurich DT; Minhas JK; Marrie TJ; Majumdar SR
Clin Infect Dis; 2010 Jul; 51(1):15-22. PubMed ID: 20504233
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
Kawakami K; Ohkusa Y; Kuroki R; Tanaka T; Koyama K; Harada Y; Iwanaga K; Yamaryo T; Oishi K
Vaccine; 2010 Oct; 28(43):7063-9. PubMed ID: 20723631
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
Vila-Córcoles A; Ochoa-Gondar O; Hospital I; Ansa X; Vilanova A; Rodríguez T; Llor C;
Clin Infect Dis; 2006 Oct; 43(7):860-8. PubMed ID: 16941367
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study.
Ochoa-Gondar O; Vila-Corcoles A; Ansa X; Rodriguez-Blanco T; Salsench E; de Diego C; Raga X; Gomez F; Valdivieso E; Fuentes C; Palacios L;
Vaccine; 2008 Apr; 26(16):1955-62. PubMed ID: 18343541
[TBL] [Abstract][Full Text] [Related]
15. Pneumonia in nursing homes and long-term care facilities.
Loeb MB
Semin Respir Crit Care Med; 2005 Dec; 26(6):650-5. PubMed ID: 16388434
[TBL] [Abstract][Full Text] [Related]
16. Streptococcus pneumoniae: does antimicrobial resistance matter?
Lynch JP; Zhanel GG
Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia in the elderly.
Loeb M
Curr Opin Infect Dis; 2004 Apr; 17(2):127-30. PubMed ID: 15021052
[TBL] [Abstract][Full Text] [Related]
18. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors.
Aspa J; Rajas O; Rodríguez de Castro F; Blanquer J; Zalacain R; Fenoll A; de Celis R; Vargas A; Rodríguez Salvanés F; España PP; Rello J; Torres A;
Clin Infect Dis; 2004 Mar; 38(6):787-98. PubMed ID: 14999620
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal polysaccharide vaccine may not prevent hospitalization for pneumonia in elderly individuals.
Skull SA; Andrews RM; Byrnes GB; Kelly HA; Nolan TM; Brown GV; Campbell DA
Clin Infect Dis; 2007 Feb; 44(4):617; author reply 617-8. PubMed ID: 17260423
[No Abstract] [Full Text] [Related]
20. What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and noninferiority trial designs for mild community-acquired pneumonia.
File TM; Schentag JJ
Clin Infect Dis; 2008 Dec; 47 Suppl 3():S157-65. PubMed ID: 18986283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
